Search

Your search keyword '"Bansal, Pranshu"' showing total 27 results
Start Over Author "Bansal, Pranshu"
27 results on '"Bansal, Pranshu"'

3. Health Data Sharing Perspectives of Patients Receiving Care in CancerLinQ-Participating Oncology Practices

Author

Jagsi, Reshma, primary, Suresh, Krithika, additional, Krenz, Chris D., additional, Jones, Rochelle D., additional, Griffith, Kent A., additional, Perry, Lydia, additional, Hawley, Sarah T., additional, Zikmund-Fisher, Brian, additional, Spector-Bagdady, Kayte, additional, Platt, Jodyn, additional, De Vries, Raymond, additional, Bradbury, Angela R., additional, Bansal, Pranshu, additional, Kaime, Melissa, additional, Patel, Monaliben, additional, Schilsky, Richard L., additional, Miller, Robert S., additional, and Spence, Rebecca, additional

Published
2023
Full Text
View/download PDF

5. Genomic landscape of lymphatic malformations: a case series and response to the PI3Kα inhibitor alpelisib in an N-of-1 clinical trial

Author

Shaheen, Montaser F, primary, Tse, Julie Y, primary, Sokol, Ethan S, additional, Masterson, Margaret, additional, Bansal, Pranshu, additional, Rabinowitz, Ian, additional, Tarleton, Christy A, additional, Dobroff, Andrey S, additional, Smith, Tracey L, additional, Bocklage, Thèrése J, additional, Mannakee, Brian K, additional, Gutenkunst, Ryan N, additional, Bischoff, Joyce, additional, Ness, Scott A, additional, Riedlinger, Gregory M, additional, Groisberg, Roman, additional, Pasqualini, Renata, additional, Ganesan, Shridar, additional, and Arap, Wadih, additional

Published
2022
Full Text
View/download PDF

6. Author response: Genomic landscape of lymphatic malformations: a case series and response to the PI3Kα inhibitor alpelisib in an N-of-1 clinical trial

Author

Shaheen, Montaser F, primary, Tse, Julie Y, primary, Sokol, Ethan S, additional, Masterson, Margaret, additional, Bansal, Pranshu, additional, Rabinowitz, Ian, additional, Tarleton, Christy A, additional, Dobroff, Andrey S, additional, Smith, Tracey L, additional, Bocklage, Thèrése J, additional, Mannakee, Brian K, additional, Gutenkunst, Ryan N, additional, Bischoff, Joyce, additional, Ness, Scott A, additional, Riedlinger, Gregory M, additional, Groisberg, Roman, additional, Pasqualini, Renata, additional, Ganesan, Shridar, additional, and Arap, Wadih, additional

Published
2022
Full Text
View/download PDF

7. Genomic Landscape of Lymphatic Malformations: A Case Series and Response to the PI3Kα Inhibitor Alpelisib in an N-of-One Clinical Trial

Author

Shaheen, Montaser F., primary, Tse, Julie Y., additional, Sokol, Ethan S., additional, Masterson, Margaret, additional, Bansal, Pranshu, additional, Rabinowitz, Ian, additional, Tarleton, Christy A., additional, Dobroff, Andrey S., additional, Smith, Tracey L., additional, Bocklage, Thèrése J., additional, Mannakee, Brian K., additional, Gutenkunst, Ryan N., additional, Bischoff, Joyce E., additional, Ness, Scott A., additional, Riedlinger, Gregory M., additional, Groisberg, Roman, additional, Pasqualini, Renata, additional, Ganesan, Shridar, additional, and Arap, Wadih, additional

Published
2022
Full Text
View/download PDF

11. Training in clinical research in India

Author

Aggarwal Sourabh, Singh Harkirat, Bansal Pranshu, Goyal Adarsh, and Singh Kalra

Subjects
Public aspects of medicine, RA1-1270
Published
2010

12. Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib with Concurrent Radiation for Newly Diagnosed Resectable Rectal Cancer

Author

Araujo-Mino, Emilio P., primary, Patt, Yehuda Z., additional, Murray-Krezan, Cristina, additional, Hanson, Joshua A., additional, Bansal, Pranshu, additional, Liem, Ben J., additional, Rajput, Ashwani, additional, Fekrazad, M. Houman, additional, Heywood, Glenory, additional, and Lee, Fa Chyi, additional

Published
2017
Full Text
View/download PDF

13. INST OX-05-024: first line gemcitabine, oxaliplatin, and erlotinib for primary hepatocellular carcinoma and bile duct cancers: a multicenter Phase II trial

Author

Patt, Yehuda Z., primary, Murad, Waheed, additional, Fekrazad, Mohammed H., additional, Baron, Ari D., additional, Bansal, Pranshu, additional, Boumber, Yanis, additional, Steinberg, Kim, additional, Lee, Sang-Joon, additional, Bedrick, Ed, additional, Du, Ruofei, additional, and Lee, Fa Chyi, additional

Published
2017
Full Text
View/download PDF

23. Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib with Concurrent Radiation for Newly Diagnosed Resectable Rectal Cancer.

Author

Araujo‐Mino, Emilio P., Patt, Yehuda Z., Murray‐Krezan, Cristina, Hanson, Joshua A., Bansal, Pranshu, Liem, Ben J., Rajput, Ashwani, Fekrazad, M. Houman, Heywood, Glenory, and Lee, Fa Chyi

Subjects
ANAL surgery, RECTUM tumors, THERAPEUTIC use of antimetabolites, ANTIMETABOLITES, CANCER patients, CLINICAL trials, COMBINED modality therapy, CONFIDENCE intervals, DIARRHEA, DRUG tolerance, LIVER, NONSTEROIDAL anti-inflammatory agents, RECTAL diseases, SKIN inflammation, SURVIVAL, CYCLOOXYGENASE 2, OXALIPLATIN, TREATMENT effectiveness, CHEMORADIOTHERAPY, DIAGNOSIS, PROGNOSIS, THERAPEUTICS, TUMOR treatment
Abstract

Copyright of Oncologist is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2018
Full Text
View/download PDF

25. Isodicentric Philadelphia chromosome: an uncommon chromosomal abnormality in the chronic phase of chronic myeloid leukemia ( CML).

Author

Loo, Eric, Bansal, Pranshu, Cherukuri, Durga, and Arana Yi, Cecilia

Subjects
*CHROMOSOMES, *CELL nuclei, *CHRONIC myeloid leukemia, *CHRONIC leukemia, *MYELOID leukemia
Abstract

Key Clinical Message An isodicentric Philadelphia chromosome is an uncommon finding previously described as a secondary chromosomal abnormality in accelerated- or blast-phase of chronic myeloid leukemia ( CML) with resistance to imatinib mesylate or dasatinib. Here, we present a case with idic(Ph) chromosome identified at initial diagnosis in a patient with chronic-phase CML. [ABSTRACT FROM AUTHOR]

Published
2016
Full Text
View/download PDF

27. Overview for the histone codes for DNA repair.

Author

Williamson EA, Wray JW, Bansal P, and Hromas R

Subjects
Animals, DNA End-Joining Repair genetics, Homologous Recombination genetics, Humans, Models, Biological, Protein Processing, Post-Translational genetics, DNA Repair genetics, Histone Code genetics
Abstract

DNA damage occurs continuously as a result of various factors-intracellular metabolism, replication, and exposure to genotoxic agents, such as ionizing radiation and chemotherapy. If left unrepaired, this damage could result in changes or mutations within the cell genomic material. There are a number of different pathways that the cell can utilize to repair these DNA breaks. However, it is of utmost interest to know how the DNA damage is signaled to the various DNA pathways. As DNA damage occurs within the chromatin, we postulate that modifications of histones are important for signaling the position of DNA damage, recruiting the DNA repair proteins to the site of damage, and creating an open structure such that the repair proteins can access the site of damage. We discuss the modifications that occur on the histones and the manner in which they relate to the type of damage that has occurred as well as the DNA repair pathways that are activated., (Copyright © 2012 Elsevier Inc. All rights reserved.)

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results